IMTX
Immatics N.V.
Latest News for IMTX
Mizuho Securities analyst Graig Suvannavejh maintained a Buy rating on Immatics today and set a price target of $23.00. Suvannavejh covers the Heal......
Guggenheim analyst Paul Jeng reiterated a Buy rating on Immatics yesterday and set a price target of $16.00. The company’s shares closed yesterday ......
Immatics ( ($IMTX) ) has provided an update. On November 12, 2025, Immatics N.V. announced updated data from its Phase 1a trials for IMA402 PRAME B......
Immatics ( ($IMTX) ) has shared an announcement. On October 27, 2025, Immatics N.V. announced the appointment of Amie Krause as Chief People Office......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD – Research Report) and Im......
News data is sourced from MarketXLS API and updated regularly.
Showing 5 of 5 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IMTX | $10.20 | +1.0% | 494.96K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |